Showing results (2111-2120 of 2,343) with videos related to
Sort By:
Pageof 235
Contemporary Clinical Trials Communications|April 24, 2023
Aniqsaaq (To Breathe): Study protocol to develop and evaluate an Alaska Native family-based financial incentive intervention for smoking cessationChristi A Patten, Kathryn R Koller, Diane K King, et al.Minerva Cardiology and Angiology|November 21, 2023
Response to interleukin-1 blockade with anakinra in women and men with ST-segment elevation myocardial infarctionGiuliana Corna, Michele Golino, Azita H Talasaz, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 10, 2024
Treatment of the neck in residual/recurrent disease after chemoradiotherapy for advanced primary laryngeal cancerJuan P Rodrigo, Fernando López-Álvarez, Jesús E Medina, et al.Journal of the International AIDS Society|November 8, 2023
Impact of point-of-care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas)Rena C Patel, Patrick Oyaro, Katherine K Thomas, et al.Journal of the American Heart Association|July 10, 2026
Efficacy and Safety of Pharmaceutically Manufactured Cannabidiol in Recurrent Pericarditis: A Phase II Clinical TrialSushil Allen Luis, Allan L Klein, Paul C Cremer, et al.British Journal of Haematology|February 26, 2013
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myelomaPeter M Voorhees, Robert F Manges, Pieter Sonneveld, et al.Annals of Hematology|March 25, 2017
Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myelomaMuhamed Baljevic, Shadia Zaman, Veerabhadran Baladandayuthapani, et al.Plos One|December 17, 2011
Genomewide association study for determinants of HIV-1 acquisition and viral set point in HIV-1 serodiscordant couples with quantified virus exposureJairam R Lingappa, Slavé Petrovski, Erin Kahle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Randomized, phase III trial of sequential epirubicin and docetaxel versus epirubicin alone in postmenopausal patients with node-positive breast cancerR Charles Coombes, Judith M Bliss, Marc Espie, et al.Arthritis Research & Therapy|April 16, 2020
Treatment modalities and drug survival in a systemic sclerosis real-life patient cohortS Panopoulos, Κ Chatzidionysiou, M G Tektonidou, et al.Pageof 235